Solving Bioavailability Challenges


Challenging API?

With E.SOLVE, we take the time to thoroughly and carefully understand your API's physicochemical profile and bioavailability needs, combining data and expertise to create a panel of formulations and testing for the optimal results.

E.SOLVE accelerates your journey to the clinic supporting as early as possible your formulation strategy from discovery to market approval.


Enhanced Formulation For Improved Bioavailability

E.SOLVE includes a full range of approaches to improve solubility and bioavailability from solubilization, solid state modification, amorphous solid dispersion, particle size reduction, and permeation enhancement.

Faster Progression Towards Clinical Answers Through:

  • A holistic approach to smart screening
  • Formulation strategy driven by molecule physico-chemical properties
  • Limited amount of API required
  • Quick delivery of fit for purpose formulations
  • Rapid access to in vivo verification
  • Integrated multidisciplinary approach to de-risk strategy
  • End-to-end support for preclinical and clinical development
  • Complete flexibility to fit your project goal
Emanuela Del Vesco

Emanuela Del Vesco

EVP Head of Global Pharmaceutical Development & Manufacturing

Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.